Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 9.82
(0.41%)
CNY 9.82
(0.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.1 Billion CNY | -8.02% |
| 2022 | 1.2 Billion CNY | 20.13% |
| 2021 | 1 Billion CNY | 23.14% |
| 2020 | 815.05 Million CNY | 2.63% |
| 2019 | 794.18 Million CNY | 2.06% |
| 2018 | 778.15 Million CNY | 80.02% |
| 2017 | 432.27 Million CNY | 64.25% |
| 2016 | 263.17 Million CNY | 0.26% |
| 2015 | 262.48 Million CNY | 32.52% |
| 2014 | 198.06 Million CNY | 19.5% |
| 2013 | 165.73 Million CNY | 11.51% |
| 2012 | 148.63 Million CNY | 35.86% |
| 2011 | 109.4 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 313.18 Million CNY | 16.38% |
| 2024 Q2 | 340.58 Million CNY | 8.75% |
| 2024 Q3 | 312.98 Million CNY | -8.1% |
| 2023 Q3 | 248.16 Million CNY | -16.09% |
| 2023 Q1 | 295.98 Million CNY | 0.55% |
| 2023 Q2 | 295.74 Million CNY | -0.08% |
| 2023 FY | 1.1 Billion CNY | -8.02% |
| 2023 Q4 | 269.11 Million CNY | 8.44% |
| 2022 FY | 1.2 Billion CNY | 20.13% |
| 2022 Q4 | 294.37 Million CNY | -10.36% |
| 2022 Q3 | 328.38 Million CNY | 8.16% |
| 2022 Q2 | 303.61 Million CNY | 8.69% |
| 2022 Q1 | 279.34 Million CNY | -5.33% |
| 2021 FY | 1 Billion CNY | 23.14% |
| 2021 Q2 | 254.01 Million CNY | 20.98% |
| 2021 Q4 | 295.08 Million CNY | 20.62% |
| 2021 Q3 | 244.63 Million CNY | -3.69% |
| 2021 Q1 | 209.96 Million CNY | -3.94% |
| 2020 Q3 | 227.53 Million CNY | 8.83% |
| 2020 Q2 | 209.07 Million CNY | 30.78% |
| 2020 Q1 | 159.86 Million CNY | -15.04% |
| 2020 FY | 815.05 Million CNY | 2.63% |
| 2020 Q4 | 218.57 Million CNY | -3.94% |
| 2019 FY | 794.18 Million CNY | 2.06% |
| 2019 Q1 | 171.57 Million CNY | -8.38% |
| 2019 Q2 | 225.64 Million CNY | 31.52% |
| 2019 Q3 | 208.79 Million CNY | -7.47% |
| 2019 Q4 | 188.17 Million CNY | -9.88% |
| 2018 Q2 | 199.51 Million CNY | 11.34% |
| 2018 FY | 778.15 Million CNY | 80.02% |
| 2018 Q4 | 187.27 Million CNY | -11.73% |
| 2018 Q3 | 212.16 Million CNY | 6.34% |
| 2018 Q1 | 179.2 Million CNY | 30.36% |
| 2017 Q2 | 103.68 Million CNY | 42.96% |
| 2017 Q3 | 118.59 Million CNY | 14.38% |
| 2017 Q4 | 137.46 Million CNY | 15.91% |
| 2017 FY | 432.27 Million CNY | 64.25% |
| 2017 Q1 | 72.52 Million CNY | -12.41% |
| 2016 Q4 | 82.8 Million CNY | 27.61% |
| 2016 Q3 | 64.88 Million CNY | 1.35% |
| 2016 FY | 263.17 Million CNY | 0.26% |
| 2016 Q1 | 51.45 Million CNY | -26.1% |
| 2016 Q2 | 64.02 Million CNY | 24.41% |
| 2015 Q2 | 72.47 Million CNY | 34.02% |
| 2015 Q1 | 54.07 Million CNY | -5.07% |
| 2015 FY | 262.48 Million CNY | 32.52% |
| 2015 Q4 | 69.63 Million CNY | 5.03% |
| 2015 Q3 | 66.29 Million CNY | -8.53% |
| 2014 Q3 | 50.32 Million CNY | -13.36% |
| 2014 Q1 | 32.69 Million CNY | -31.35% |
| 2014 FY | 198.06 Million CNY | 19.5% |
| 2014 Q2 | 58.08 Million CNY | 77.66% |
| 2014 Q4 | 56.96 Million CNY | 13.2% |
| 2013 Q4 | 47.61 Million CNY | 12.7% |
| 2013 Q3 | 42.25 Million CNY | 0.0% |
| 2013 FY | 165.73 Million CNY | 11.51% |
| 2012 FY | 148.63 Million CNY | 35.86% |
| 2011 FY | 109.4 Million CNY | 0.0% |